Marinova is an Australian biotechnology company dedicated to the development and production of high purity seaweed extracts for the betterment of human health. Marinova specialises in the manufacture of fucoidan compounds for use in the nutritional, pharmaceutical, animal health, skincare and dermatology sectors.
Marinova possesses a unique ability to extract high purity, nature-identical fucoidans from a range of seaweed species. The result is a suite of highly characterised fucoidan compounds with specific and targeted bioactivities and global regulatory acceptance. Marinova’s core product range includes: Maritech® Undaria pinnatifida fucoidan extract, Maritech® Fucus vesiculosus fucoidan extract, Fucorich®, Maritech® Synergy, Maritech® Reverse, Maritech® Bright, and MariVet®.